Pic for representational purpose only.
SAO PAULO, June 11
Brazil health regulator Anvisa on Friday said it had approved use of the Pfizer/BioNtech COVID-19 vaccine for children over 12 years of age.
Anvisa said it approved the measure after seeing studies, conducted outside Brazil, that showed safety and efficacy for the age group.
The vaccine, the first in Brazil to receive definitive approval from Anvisa, was already authorized for use on adolescents aged 16 and over, the regulator said. It added that the Pfizer vaccine was currently the only one authorized to be used on minors.
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Deeply biased: MEA on US report citing human rights violations in India
The annual report of the State Department highlights instanc...
Couldn't talk due to strictness of jail authorities: Amritpal's family after meeting him in jail
Their visit comes a day after Singh's legal counsel Rajdev S...
Centre grants 'Y' category security to Phillaur MLA Vikramjit Chaudhary and 2 other Punjab Congress rebels
The Central Reserve Police Force has been directed by the Mi...
First Sikh court opens in UK to deal with family disputes
According to ‘The Times’, the Sikh court was launched last w...
